1. Home
  2. EARN vs WHWK Comparison

EARN vs WHWK Comparison

Compare EARN & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EARN

Ellington Residential Mortgage REIT of Beneficial Interest

HOLD

Current Price

$4.64

Market Cap

173.2M

Sector

Real Estate

ML Signal

HOLD

WHWK

Whitehawk Therapeutics Inc.

HOLD

Current Price

$3.92

Market Cap

179.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EARN
WHWK
Founded
2012
2007
Country
United States
United States
Employees
N/A
22
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
173.2M
179.8M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
EARN
WHWK
Price
$4.64
$3.92
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$5.38
$7.00
AVG Volume (30 Days)
396.7K
170.8K
Earning Date
03-04-2026
05-07-2026
Dividend Yield
20.82%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.69
N/A
Revenue Next Year
$19.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.27
$1.39
52 Week High
$6.08
$4.40

Technical Indicators

Market Signals
Indicator
EARN
WHWK
Relative Strength Index (RSI) 52.01 62.91
Support Level $4.43 $1.84
Resistance Level $5.36 $4.40
Average True Range (ATR) 0.10 0.25
MACD 0.04 0.01
Stochastic Oscillator 83.33 99.36

Price Performance

Historical Comparison
EARN
WHWK

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.

About WHWK Whitehawk Therapeutics Inc.

Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.

Share on Social Networks: